FDA.reportPublic FDA data

secnidazole 2 GM Oral Granules

RxCUI
1946692
RxNorm name
secnidazole 2 GM Oral Granules
Display name
secnidazole 2 GM Oral Granules
Full name
secnidazole 2 GM Oral Granules
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
056485b6-8bba-4a21-ae00-cdb4e7ae4bfasecnidazole 2 GM Oral Granules [PSN] · secnidazole 2000 MG Oral Granules [SCD] · secnidazole 2 GM Oral Granules [SY]31These highlights do not include all the information needed to use SOLOSEC ® safely and effectively. See full prescribing information for SOLOSEC. SOLOSEC ® (secnidazole) oral granules Initial U.S. Approval: 201720250219